Why Is Organigram (OGI) Stock Up 25% Today?

Group 1 - Organigram reported C$41.06 million in revenue for its fiscal third quarter, exceeding Wall Street's expectation of C$39.24 million, representing a 25% year-over-year increase from C$32.8 million [1][2] - The revenue increase is primarily attributed to higher recreational cannabis sales and the expansion of international supply agreements [2][3] - The company highlighted a significant improvement in adjusted EBITDA and strategic investments, particularly in the European market through its investment in Sanity Group [3] Group 2 - Following the positive earnings report, Organigram's stock rose by 25.4%, with trading volume exceeding 2.4 million shares, significantly above its daily average of approximately 695,000 shares [3][4]